| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a281f722e226b324dda7c912550873a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b06f61bd8236ed59687f610ba116350
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24c427af6d51e58385291cff9a803f00 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
| filingDate |
2012-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7434881703f6d7fb556909adaabe6b92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52949efa4a08fb7b50f5c57378601623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05b7d9bc2f51c50ef2a6ebad43aea052 |
| publicationDate |
2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013130386-A1 |
| titleOfInvention |
Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods |
| abstract |
Modified antigen presenting cells provided herein have improved lifespan and immunogenicity compared to unmodified antigen presenting cells, and are useful for immunotherapy. The modified antigen presenting cells express an altered protein kinase, referred to herein as “Akt.” The altered Akt associates with the cell membrane with greater frequency than unaltered Akt, and is referred to herein as “membrane-targeted Akt.” |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3687575-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105520400-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021024264-A3 |
| priorityDate |
2006-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |